美國居民不適用 XM 服務。
A
A

AstraZeneca

交易方向

交易者脈動

技術摘要

小時

財經新聞

UK corporate earnings week ahead

DIARY-UK corporate earnings week ahead April 19 (Reuters) - Diary of U.K (.FTSE) corporate earnings for the week ahead UK EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 23-Apr-2024 NTS ABF.L Associated British Foods PLC Half Year 2024 Associated British Foods PLC Earnings Release 25-Apr-2024 06:00 BARC.L Barclays PLC Q1 2024 Barclays PLC Earnings Release 25-Apr-2024 06:00 SBRY.L J Sainsbury PLC Full Year 2024 J Sainsbury PLC Earnings Release 25-Apr-2024 06:00 AZN.L AstraZeneca
A
B
A
U

Asher Bio Closes $55 Million Series C Financing Led By RA Capital Management

BRIEF-Asher Bio Closes $55 Million Series C Financing Led By RA Capital Management April 16 (Reuters) - AstraZeneca PLC AZN.L : ASHER BIO - CLOSES $55 MILLION SERIES C FINANCING LED BY RA CAPITAL MANAGEMENT ASHER BIO - FUNDING ROUND HAD PARTICIPATION FROM EXISTING INVESTORS AND ADDITIONAL NEW INVESTORS, INCLUDING ASTRAZENECA AND BRISTOL MYERS SQUIB
A

Top of the Street: AstraZeneca, Barry Callebaut, Ahold Delhaize, Voestalpine

BUZZ-Top of the Street: AstraZeneca, Barry Callebaut, Ahold Delhaize, Voestalpine A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank raises London-listed drugmaker AstraZeneca AZN.L to "hold" from "sell", as it sees a 'rich' 2025 catalyst list with slightly improving perspective on Farxiga's EPS impact - AstraZeneca's blockbuster diabetes drug ** UBS raises Swiss chocolate maker Barry Callebaut BARN.S to "neutral" from "sell", citing its recen
A
D
V
A

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains By Patricia Weiss and Ludwig Burger INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer BAYGn.DE as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).
A
B

Admiral, Auto Trader, BBVA

EUROPE RESEARCH ROUNDUP-Admiral, Auto Trader, BBVA April 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral, Auto Trader and BBVA on Tuesday. HIGHLIGHTS * Admiral ADML.L : RBC raises target price to 3400p from 2600p * Auto Trader AUTOA.L : Citigroup raises target price to 711p from 700p * BBVA BBVA.MC : Citigroup raises target price to EUR 11.9 from EUR 11 * Phoenix PHNX.L : Barclays cuts to underweight from overweight * SG
A
A
A
A
A
A
A
A
A
B
C
C
C
C
E
E
G
H
J
L
M
N
N
A
A
A
A
B
F

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明